chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report as received from a physician refers to a patient of unknown age and gender. No information on medical history, concurrent conditions or concomitant drugs was provided. On an unknown date the patient was vaccinated with a dose of MMR II, route and site of injection, therapy type, lot# and expiration date not reported. Other suspect therapies included vaccination (on an unknown date) with VARIVAX, route and site of injection, lot# and expiration date not provided. On an unknown date the patient had a blood test showing low titers (non-immunity) for rubella and varicella. On an unknown date the patient sought medical attention, method unspecified. The outcome of the adverse event was unknown. Relatedness between use of MMR II and VARIVAX and the adverse event was not reported. Additional information has been requested.
Large bruise at injection site though he was gentle. It grew large and remained several days sudden onset of herpes in mouth, lips and face - though hadn't had such a severe case in past. Took my usual treatment of Lysine which usually works, but sores only got worse. When started got pain in back of neck - took ZOVIRAX - worked so didn't go to ER.
Systemic: Chills-Medium, Systemic: Fever-Severe, Systemic: Nausea-Medium, Systemic: Shakiness-Medium, Systemic: Vomiting-Medium, Systemic: Weakness-Medium, Additional Details: Patuent began to feel nauseaus and began shaking several hours after recieving vaccine.  He vomited several times and spiked a fever of 104 degrees.  He took ibuprofen for symptoms - he did not seek medical care.  Symptoms began to subside after 12 pm.  He still had a fever but that went away by morning.  He continued to feel weak and nauseaus for a couple of days.
Shot at 5:40 PM. Chills and shaking 6 hours after until the morning. Day 1- loss of appetite, nausea, migraine and light sensitivity. Fever 102. Shaking, sweating and chills. Fatigue. Throwing up at night. Arm soreness  Day 2- fever hovering around 103-104 for almost 24 hours. Threw up in morning. Migraine dissipated to a headache. No arm pain. No appetite  Day 3 - woke up sweaty - ~100 temp. Arm pain but no headache.  Temp down to 98.7 by afternoon-ish. No appetite  Day 4- extreme right arm pain beyond soreness at injection site. Inability to move arm laterally. No fever minor chills. Extreme exhaustion (hangover effect from fever probably!) appetite coming back!
Swelling at injection site. A few days later "blistering like a sunburn" at injection site. 4-6 days later, upset stomach, feverish.
Right ear pain started on 1/16/21. I was diagnosed with right sided facial nerve shingles on 1/20/21 at regular oncology appointment. 10/10 pain. I blacked out and drove off the road, fell down a flight of stairs. Rapid onset of pain. Infectious disease MD placed me on Valtex and Gabapentin. I missed 2 weeks of work. I am still on the Valtrex 9 months later and Infectious Disease feels that med will be needed at least until 1/22. I have lost some hearing in my right ear in addition to feeling/taste buds on the entire right side of my face. The vision deficit on the right side cleared after about a month. Right sided numbness, tingling, loss of sensation continue. Acute pain has subsided.
Fever, headache. Thrombocytopenia, neutropenia. Admitted, no treatment. 10/7/09 Medical records received from dates 9/8/09 to 9/10/09 DC DX: Leukopenia, thrombocytopenia.  Presenting SX:  fever, neck pain/stiffness, myalgias, sweats, chills, HA, nausea, poor appetite. Symptoms occured  x1 day after flu vaccine. ICD9 codes: 288.5, 287.5  11/30/2009 MR and DC summary for 9/10-9/11/2009 transfer to this facility for continued care, received IV ABX, DC Dx fever/headache, thrombocytopenia, neutropenia
This morning (2/14/2020) began feeling cold and not very well.  Took temperature - 100 degrees F.  Took temperature again about 4:30 PM - 101 degrees F.  I just generally don't feel well. Have not received any treatment or notified any doctor.  It is Sunday.
only the diluent portion of the Menveo vaccine.; only the diluent portion of the Menveo vaccine; This case was reported by a nurse via call center representative and described the occurrence of inappropriate preparation of medication in a 16-year-old male patient who received Men ACWY-CRM NVS (Menveo) (batch number amxa415a, expiry date 20th August 2022) for prophylaxis.   On 9th August 2021, the patient received Menveo. On 9th August 2021, unknown after receiving Menveo, the patient experienced inappropriate preparation of medication and inappropriate dose of vaccine administered. On an unknown date, the outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown.  Additional details were provided as follows: Nurse reported that a patient was given only the diluent portion of the Menveo vaccine, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered. The heath care professional had no further information on the event. The reporter consented to follow-up.
Patient experiencing some residual pain- no redness or swelling at the injection site upon physical inspection 1/25/23 12:05pm. Suggested patient try taking Motrin for a few days and applying ice as needed to help with the inflammation. Asked patient to follow up in a couple weeks and talk to MD if pain continues.
My arm swelled up and it was tender. Pain for worst to where I couldn't lift my arm. Pain went up to my neck. Went to Dr and got steroids and pain medicine.  It helped for a little while but returned to Dr and told her I was having trouble moving my arm. I have not fully recovered.  Dr ordered MRI but I can not afford it at this time. I am having trouble sleeping because of my arm and shoulder pain.
Initial report received on 03 August 2012 from the Investigator participating in a post-marketing observational surveillance study. A case of pertussis disease in a 15-month-old male subject (initials not collected) was identified by the investigator based on review of data from the State Electronic Disease Surveillance electronic database. The subject had received 3 doses of PENTACEL; received on 06 May 2011, 01 July 2011 and 26 September 2011 (lot numbers, routes and sites of administration not reported). The subject developed cough and cold-like symptoms on 06 June 2012, approximately eight months after the last dose. On 20 June 2012, the subject developed a paroxysmal cough without a whoop. The subject also experienced posttussive vomiting, apnea and sleep disturbance. Laboratory testing included positive PCR on 21 June 2012. Corrective treatments consisted of azithromycin starting on 21 June 2012 for 5 days. The subject was not hospitalized. At the time of final contact on 26 June 2012, the subject's cough was still persisting. The duration of the cough was reported at that time as 15 days. Investigator causality assessment is not required as per protocol. Documents held by sender: None.
pt recv vax & approx 1 wk post vax pt exp severe arthralgia & myalgia;sx cont for 2 wk  & resolved over 1month;
Skin reaction; This spontaneous case was reported by a pharmacist and describes the occurrence of SKIN REACTION (Skin reaction) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     No Medical History information was reported.    In September 2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced SKIN REACTION (Skin reaction). The patient was treated with PREDNISONE at an unspecified dose and frequency. At the time of the report, SKIN REACTION (Skin reaction) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication information was provided. She had the moderna covid 19 vaccine on September and got a bad skin reaction to it. Her doctor told her to start the whole series over with the Pfizer Biontech COVID 19 vaccine instead so in november she got her first dose and she had the appointment for the second dose yesterday 27 Dec 2021. patient was not immunocompromised. She did not feel comfortable administering a third dose of covid vaccine to the patient. This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.
Patient started to develop blister-like eruptions on facial area above lip and on right side of nose, starting on 4/4/11 (3 days following vaccination). She was advised to consult Primary Care Physician for treatment after reporting to pharmacy on 4/6.
Initially red arm w/mild swelling that resolved  by Sat 1/30 Now with redness, warmth, swelling approx  2" x 3"
This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm), VACCINATION SITE WARMTH (Arm hot/now it's warmer) and VACCINATION SITE ERYTHEMA (A red spot/nowit's redder) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037A21B) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no reported medical history). Concomitant products included AMLODIPINE for an unknown indication.    On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. On 08-Apr-2021, the patient experienced PAIN IN EXTREMITY (Sore arm). On 09-Apr-2021, the patient experienced VACCINATION SITE WARMTH (Arm hot/now it's warmer) and VACCINATION SITE ERYTHEMA (A red spot/nowit's redder). At the time of the report, PAIN IN EXTREMITY (Sore arm), VACCINATION SITE WARMTH (Arm hot/now it's warmer) and VACCINATION SITE ERYTHEMA (A red spot/nowit's redder) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.
transverse myelitis; neuropathy from his waist down; This is a spontaneous report from a contactable consumer (patient). This consumer reported similar event for two patients. This is the first of two reports.  A 41-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), (at the age of 41 years old) via an unspecified route of administration, administered in Arm Right on 24May2021 (Batch/Lot Number: EW0186) as dose 2, single for covid-19 immunisation. The patient has no medical history and concomitant medications. The patient had the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot: EW0176) via an unspecified route of administration in the left arm on 03May2021 10:00 (at the age of 41 years old) for COVID-19 immunization and experienced brain fog, a lot of digestive issues and still has a huge knot on his left arm and it has remained the same and is as hard as a rock (the patient had the 2nd dose administered in his right arm and it has no knot on that arm). No additional vaccines administered on same date of the Pfizer suspect and no prior vaccinations within 4 weeks. The patient was diagnosed with transverse myelitis on 09Sep2021 per his 'MyChart'. The patient that stated they have been doings tests and treatment running over the last few months. The patient had four MRIs, a spinal tap and blood tests. The results of the MRI showed white matter on his spine at T2 and the neurologist diagnosed him with transverse myelitis. For the first symptoms of transverse myelitis, he lost all feeling in his legs and had numbness and tingling and now neuropathy from his waist down and that happened on 16Aug2021 and the hospital emergency room visit was on 19Aug2021 in the hospital outpatient and saw his doctor on 16Aug2021. On 17Aug2021, they did the MRI and thought this was Guillian Barre syndrome as it has the same side effects but ruled out Guillian Barre syndrome. He went on 19Aug2021 for admission to the emergency room and had tingling up to his chest and down to his feet including all his extremities and spent two nights in the hospital admitted on 19Aug2021 and discharged on 21Aug2021. The only other thing was that until he took the vaccine, he had not been to the HCP in two years for anything and since he took the vaccine not counting all the follow up visits to the doctor five times for different ongoing symptoms and since then he has been doing research. The patient stated that in hospitals and with doctors, his neurologist said they had a spike in cases of transverse myelitis since people have been taking the vaccine; his chiropractor said there has been a spike in his patients coming to him for relief as well in the last 8-10 months. The outcome of the event transverse myelitis was not recovered while the other event was unknown.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202101312448 same reporter/drug, similar event, different patients
After patient received injection she began feeling dizzy sat for approximately 10 minutes felt fine and went home. Later developed rash on knees and legs. Mom gave her Benadryl and resolved. This is in follow-up to report (s) previously submitted on 6/14/2007. Information has been received from a nurse practioner, concerning a 17 year old white female who on 10-May-2007 was vaccinated IM, with the first dose GARDASIL. Following the vaccination, the patient felt dirty while still in the physician's office, she sat down for 10 minutes and was fine. Later that day, 10-May-2007, she developed a rash on her legs; treament with BENADRYL brought relief of the rash "off and on" at different locations. At the time of this report, the outcome of the rash was unknown. Additional information is not expected.
Nausea, vomiting and diarrhea (2 days) Dizziness and lightheadedness (2 days) Vertigo (has been 10 days and is currently happening) Ringing in the ears Brain fog (5 days) Symptoms are ongoing and have decreased only slightly as of this report
Admitted with breakthrough COVID-19 infection on 10/14/21. Altered mental status over previous 3 days
yesterday 7/26/2021 Patient experienced an asthma attack - she resorted to her emergency inhaler for immediate relief while she does have a medical history with asthma, she HAD NOT had any episodes in at least 5 years.
Immediate localized swelling. Patient did not complain of pain or itching, but became lightheaded immediately after standing up.
patient was administered only the adjuvant component of Shingrix.; patient was administered only the adjuvant component of Shingrix.; This non-serious case was reported by a other health professional via call center representative and described the occurrence of inappropriate preparation of medication in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced inappropriate preparation of medication (Verbatim: patient was administered only the adjuvant component of Shingrix.) and inappropriate dose of vaccine administered (Verbatim: patient was administered only the adjuvant component of Shingrix.).  The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown.   Additional Information: GSK Receipt Date: 06-OCT-2023 Pharmacy student reports a patient was administered only the adjuvant component of Shingrix, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered. The reporter consented to follow up. This happened at a nursing home not at the pharmacy and  HCP had no information about the patient or when it happened  follow-up was ok at the address above and it could be send it to ATTN: pharmacist in charge.
My arm is red and is itchy; My arm is red and is itchy; This spontaneous case was reported by a patient and describes the occurrence of PRURITUS (My arm is red and is itchy) and ERYTHEMA (My arm is red and is itchy) in a 79-year-old male patient who received mRNA-1273.815 (SPIKEVAX 2023-2024) (batch no. ASKU) for COVID-19 prophylaxis.     No medical history was reported.  Concomitant products included INFLUENZA VACCINE (FLU VACCINE VII) for an unknown indication.    On 14-Oct-2023, the patient received fourth dose of mRNA-1273.815 (SPIKEVAX 2023-2024) (unknown route) 1 dosage form. In October 2023, the patient experienced PRURITUS (My arm is red and is itchy) and ERYTHEMA (My arm is red and is itchy). At the time of the report, PRURITUS (My arm is red and is itchy) and ERYTHEMA (My arm is red and is itchy) had not resolved.            The patient had Flu vaccine within the same month.  Concomitant medication not reported.   Treatment medication not reported.
The day following my vaccination, my arm at the injection site was very tender and sore, more so than any other shot I had had before. The area around the injection site was also noticeably warmer than my normal skin temperature.
REBOUND COVID; This spontaneous report received from a patient via other manufacturer (Pfizer) concerned a 55 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included: COPD (Chronic obstructive pulmonary disease), and non-hodgkins lymphoma remission for 10 years, and other pre-existing medical conditions included: patient had none allergy. The patient received covid-19 vaccine ad26.cov2.s (Dose number in series 1) (suspension for injection, route of admin, and batch number were not reported, expiry: unknown) dose was not reported, 1 total, administered at right arm on 25-MAR-2021 for prophylactic vaccination. Age at time of vaccination 54 years old. The batch number was not reported and has been requested. It was unknown whether patient had any adverse events following vaccination with first dose of covid-19 vaccine ad26. cov2.s (Dose number in series 1). No concomitant medications were reported.  The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient received booster dose of non-company suspect vaccine included: Pfizer covid-19 vaccine (Tozinameran) (Dose number in series 2) (form of admin, route of admin was not reported, batch number: unknown expiry: unknown) dose was not reported, administered on an unspecified date in Nov-2021 for prophylactic vaccination. Treatment medications included: Paxlovid (ritonavir/nirmatrelvir) from 25-MAY-2022 to 30-MAY-2022 for the treatment of covid-19. On 07-JUN-2022, the patient experienced rebound covid (Dose number in series 2). The action taken with tozinameran (Pfizer covid-19 vaccine) was not applicable. The patient was recovering from rebound covid. This report was non-serious.
I'm still light headed, dizzy, and a little confused sometimes.; I'm still light headed, dizzy, and a little confused sometimes.; I'm still light headed, dizzy, and a little confused sometimes.; The second round was 3 days ago; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 29 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 06Feb2022 11:30 (Lot number: fl3209) at the age of 29 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "known allergies: Avocado" (unspecified if ongoing); "Bipolar 2" (unspecified if ongoing); "Depression" (unspecified if ongoing); "GAD" (unspecified if ongoing); "PMDD" (unspecified if ongoing); "Arthritis" (unspecified if ongoing). Concomitant medication(s) included: LAMICTAL. Vaccination history included: Bnt162b2 (Dose 1, Single, lot number: FJ5682,, administration time: 10:30AM, vaccine location: Left arm), administration date: 16Jan2022, when the patient was 29 years old, for COVID-19 Immunization, reaction(s): "monthly cycle started 2 weeks early, was much worse than usual, experienced excessive blood clots with the first round", "monthly cycle started 2 weeks early, was much worse than usual, experienced excessive blood clots with the first round", "Light headed/dizzy", "A little confused sometimes". The following information was reported: DIZZINESS (non-serious), DIZZINESS (non-serious), CONFUSIONAL STATE (non-serious) all with onset Feb2022, outcome "not recovered" and all described as "I'm still light headed, dizzy, and a little confused sometimes."; MENSTRUAL DISORDER (non-serious) with onset Feb2022, outcome "unknown", described as "The second round was 3 days ago".  Additional information: Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine.  No follow-up attempts are possible. No further information is expected.
pt recv vax JAN96 & 18MAY97 pt devel shingles;pt was seen by MD;
Experienced a loss in her voice for a few days; This spontaneous case was reported by a consumer and describes the occurrence of APHONIA (Experienced a loss in her voice for a few days) in a 3-decade-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Nov-2021, the patient experienced APHONIA (Experienced a loss in her voice for a few days). In November 2021, APHONIA (Experienced a loss in her voice for a few days) had resolved.            Concomitant medication was not provided. Treatment medication was not provided.
first dose had given it way high up on the shoulder bone and it hurt like crazy.; first dose had given it way high up on the shoulder bone and it hurt like crazy.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 57-year-old female patient received BNT162b2 (BNT162B2), on 06Mar2021 as dose 1, single (Lot number: EN6198) at the age of 55 years, in left arm for covid-19 immunisation. The patient had no relevant medical history. Concomitant medication(s) included: FLU taken for immunisation, start date: 05Oct2021, stop date: 05Oct2020. Vaccination history included: flu vaccine , administration date: 05Oct2020, when the patient was 55-year-old, for Immunization; Shingles shot (she has had other vaccines that were given high up like with her Shingles shot, and that hurt), reaction(s): "hurt". The following information was reported: PRODUCT ADMINISTERED AT INAPPROPRIATE SITE (non-serious), VACCINATION SITE PAIN (non-serious) all with onset Mar2021, outcome "unknown" and all described as "first dose had given it way high up on the shoulder bone and it hurt like crazy." Additional information: Caller told the person administering that second dose that the person who gave the caller her first dose had given it way high up on the shoulder bone and it hurt like crazy. Caller stated that the person give her the second dose know about that so they could get it in deltoid. Caller said she did not feel any soreness or anything at all with that second dose. Caller had no soreness afterwards.
Swelling, induration 1" diameter Day 2. By Day 4 same induration but erythema 5-6".
Initial soreness then development of two 2-3 inch red areas below injection site. Subsequent joint pain in ensuing days, severe hives in response to scratching red areas on6/20/16. Treated with benadryl gel and took benadryl, subsided over night. Red areas remained for about 10 days. Developed acute pain in knee/leg that seemed to be triggered by initial joint pain. Largely disappeared by July 1. Note that discomfort, soreness became cyclical on a diurnal basis. Disappeared at night, increased upon rising and then decreased in evening.
It was reported post vaccine pt developed local reaction of redness and swelling. Follow up 5/14/02: during internal review of all files, it was deemed necessary to amend the report (corrected vaccination date to 2/3/00 adn the reaction date to 2/4/00 at it appears on the initial contact report).